skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Treatment of pediatric pulmonary hypertension

Review

(3499) Views  (1281) Full article downloads

Authors: Amy Hawkins, Robert Tulloh

Published Date June 2009 Volume 2009:5 Pages 509 - 524
DOI: http://dx.doi.org/10.2147/VHRM.S4171

Amy Hawkins, Robert Tulloh

Department of Congenital Heart Disease, Bristol Royal Hospital for Children, Bristol UK

Abstract: Pulmonary hypertension was once thought to be a rare condition and only managed in specialized centers. Now however, with the advent of echocardiography, it is found in many clinical scenarios, in the neonate with chronic lung disease, in the acute setting in the intensive care unit, in connective tissue disease and in cardiology pre- and postoperatively. We have a better understanding of the pathological process and have a range of medication which is starting to be able to palliate this previously fatal condition. This review describes the areas that are known in this condition and those that are less familiar. The basic physiology behind pulmonary hypertension and pulmonary vascular disease is explained. The histopathologic process and the various diagnostic tools are described and are followed by the current and future therapy at our disposal.

Keywords: pulmonary hypertension, congenital heart disease, pulmonary vascular resistance, pulmonary vasodilators








Readers of this article also read:

An evaluation of dry eye symptoms and signs in a cohort of children with juvenile idiopathic arthritis
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Effects of efforts to intensify management on blood pressure control among patients with type 2 diabetes mellitus and hypertension: A pilot study
Metabolic syndrome and cardiovascular disease in South Asians
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Childhood obesity: A comparison of health habits of middle-school students from two communities
Bactericidal effects of silver plus titanium dioxide-coated endotracheal tubes on Pseudomonas aeruginosa and Staphylococcus aureus
Role of olmesartan in combination therapy in blood pressure control and vascular function
ABO and rhesus blood group distribution in Kurds
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University